Overall a great opportunity - werkgeversreview Senior Engineer bij Merck

4,0
22 jan 2009
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Merck is a great place for benefits and recognition (such as lunch passes, movie tickets, award dinners, and just notes to say thank you), in my department at least. They recently increased the number of vacation days we get per year. They also just started a more flexible work week where you can work from home part time, have a 4 day work week, or other arrangements. Also, since the company is so large, there is a lot of opportunity to move around and try new positions and become more well rounded. The people I work with are the best! They keep me coming back every day with the family-type atmosphere.

Minpunten

Right now things are in a a transition state -- we are implementing SAP, which in the end should make day to day transactions easier, but in the mean time is creating quite a stir. Many trainings and "hyper-care" stages are on their way! Senior management is sometimes inaccessable, in a way they seem to be making decisions on their own and there is a very subdivided oganization, but I know there are strategies in place to make this better, so I am optimistic for now.

Ontdek andere reviews over Merck

5,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent company to work with.

Minpunten

No cons encountered so far

4,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Minpunten

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle